Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
RAS/RAF Pathway Mutation Profile (KRAS and NRAS reflex to BRAF) Molecular Oncology Laboratory, LabCorp United States | 6 | 3 |
|
Molecular Oncology Laboratory, LabCorp United States | 5 | 1 |
|
GeneDx United States | 103 | 82 |
|
Common Cancer Management Panel GeneDx United States | 56 | 37 |
|
Breast Cancer Management Panel GeneDx United States | 24 | 9 |
|
GeneDx United States | 46 | 24 |
|
Comprehensive Common Cancer Panel GeneDx United States | 60 | 47 |
|
CEN4GEN Ovarian cancer: Extended gene sequencing Panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 32 |
|
Hereditary Breast/Ovarian Cancer Panel Genetic Services Laboratory University of Chicago United States | 16 | 20 |
|
BRCA1, BRCA2, and TP53 Mutation Analysis Genetic Services Laboratory University of Chicago United States | 6 | 3 |
|
BRCA1, BRCA2, and PALB2 Mutation Analysis Genetic Services Laboratory University of Chicago United States | 6 | 3 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 4 | 24 |
|
MGZ Medical Genetics Center Germany | 25 | 1 |
|
Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University United States | 3 | 7 |
|
Circulogene Theranostics United States | 1 | 1 |
|
Circulogene Theranostics United States | 1 | 1 |
|
Circulogene Theranostics United States | 1 | 1 |
|
Circulogene Theranostics United States | 1 | 1 |
|
Lynch/Colorectal High Risk Panel GeneDx United States | 10 | 7 |
|
BRCA1/2 Sequencing and Del/Dup Analysis GeneDx United States | 11 | 2 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.